Medical/Pharmaceuticals
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 28 at 9:30 CEST
STOCKHOLM, Oct. 21, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOGunilla Andersson. To register for the presentation of ...
2021-10-21 16:28
2170
Guangzhou Concord Cancer Center Becomes a Designated Hospital of Social Healthcare Insurance
BEIJING, Oct. 21, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...
2021-10-21 16:00
9398
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates
SHANGHAI and HONG KONG, Oct. 21, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
2021-10-21 16:00
4346
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray
SHANGHAI, Oct. 21, 2021 /PRNewswire/ -- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (''Shandong Luoxin''), a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. ("Luoxin Pharmaceutical" or "the company") , signed a licensing agreement withAustria-based Marinomed Biotech AG ("Mar...
2021-10-21 15:58
2025
UNO Technologies announces collaboration with Aetos Pharma to further accelerate Malaysia's healthcare tech transformation
SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- UNO Technologies, a rapidly growing Medical Technology ("med tech") firm based inSingapore, has recently announced its expansion into the Malaysian market. As part of its regional strategy, UNO will team up with Aetos Pharma, a burgeoning Malaysian pharmac...
2021-10-21 12:38
4609
IND Application for Phase III Clinical Study of Anti-HER2 Bispecific Antibody KN026 was Officially Accepted by CDE
SUZHOU, China, Oct. 21, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced IND application for a phase III clinical study of recombinant humanized anti-HER2 bispecific antibody KN026 (KN026-306) was official...
2021-10-21 10:31
3595
Singapore-based Biosyngen receives 500 million yuan in investment
SINGAPORE, Oct. 21, 2021 /PRNewswire/ -- At the 12th Singapore-Guangdong Collaboration Council (SGCC) meeting held online onOctober 20, Singapore-based Biosyngen Pte. Ltd. ("Biosyngen") announced its partnership with wholly state-owned Chinese company Science City (Guangzhou) Investment Group Co....
2021-10-21 09:30
7557
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.
DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a
scientific paper from GenKOre on the new hypercompact CRISPR system called
CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF
54.9), one of the world's top-tier biotechnology journals.
2021-10-21 09:05
1976
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research
PERTH, Australia and TAIPEI and SHANGHAI, Oct. 20, 2021 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the first patient with metastatic sigmoid adenocarcinoma has been dosed inPerth, Aus...
2021-10-21 08:05
2483
EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization
CHICAGO and KANSAS CITY, Mo., Oct. 20, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, andIntouch Group®, a full-service global agency network serving the pharmaceutical industry, today announced that they signed an agreemen...
2021-10-20 22:34
4848
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine
VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA:5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that it has filed with the United States Patent & Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen va...
2021-10-20 21:24
5623
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference
* Statistically significant 133% faster time to COVID-19 clinical symptoms recovery versus standard of care (SOC)/best supportive care. * Statistically significant 114% faster time to reach EQ-5D-5L Q6 ≥ 90% versus SOC/best supportive care. * Statistically significant 57% faster time to norm...
2021-10-20 20:52
2729
Seoul Gangnam-gu kicks off 2021 Medical Tourism Brand Festa
SEOUL, South Korea, Oct. 20, 2021 /PRNewswire/ -- Gangnam-gu (the Mayor of
Gangnam-gu, Jeong sungun) is holdiong the '2021 Gangnam Medical Festa' in
Nonhyeon-ro and Sinsa-ro areas for the month of October with the theme of
'Gangnam connected to the world, Gangnam, a healthy medical city'.
2021-10-20 20:05
2422
Island Pharmaceuticals to discuss its potential dengue fever preventative at Pharma Meeting Brazil & Latam 2021
MELBOURNE, Australia, Oct. 20, 2021 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to be attending Pharma Meeting Brazil & Latam 2021, this week and presenting to potential partners. Island's attendance at the co...
2021-10-20 18:00
3422
HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology
SINGAPORE, Oct. 20, 2021 /PRNewswire/ -- HistoIndex
2021-10-20 18:00
2239
Xinhua Silk Road: 52nd Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi
BEIJING, Oct. 20, 2021 /PRNewswire/ -- The 52nd Zhangshu National Traditional
Chinese Materia MedicaTrade
2021-10-20 17:27
4265
A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.
DAEJEON, South Korea, Oct. 20, 2021 /PRNewswire/ -- On September 2, 2021, a
scientific paper from GenKOre on the new hypercompact CRISPR system called
CRISPR/Cas12f-GE was published in an online issue of Nature Biotechnology (IF
54.9), one of the world's top-tier biotechnology journals.
2021-10-20 15:31
4229
Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"
GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...
2021-10-20 15:19
4202
Action for bone health is needed now more than ever, urges IOF
NYON, Switzerland, Oct. 20, 2021 /PRNewswire/ -- A backlog in osteoporosis assessments, treatment delays, and sedentary indoor lifestyles: these are just several ways in which the Covid-19 pandemic has impacted bone health and disrupted global osteoporosis care. Osteoporosis is a common bone dis...
2021-10-20 13:30
4119
Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources
Financial commitment aims to secure dedicated, low-cost supply of molnupiravir, if the drug is authorized by regulators; builds on long-term efforts to increase access to tests, treatments, vaccines SEATTLE, Oct. 20, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today a comm...
2021-10-20 13:29
3183
Week's Top Stories
Most Reposted
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 294 media titles]
2026-09-24 10:30
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 278 media titles]
2026-09-29 09:00
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 278 media titles]
2026-09-28 23:04
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
DOKU Names Himelda Renuat CEO as Ant International's Antom Deepens Strategic Investment in Indonesia's Payments Leader
[Picked up by 274 media titles]
2026-09-24 10:00
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
13883
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
12600
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
11636
